Skip to main content
. Author manuscript; available in PMC: 2015 Sep 3.
Published in final edited form as: Thorax. 2014 Jan 24;69(6):565–573. doi: 10.1136/thoraxjnl-2013-204605

Fig 1. 1018 ISS treatments progressively suppress airway Th2 responses.

Fig 1

A, Tx protocol 1: 1, 3, 8, or 17 weekly intranasal saline, RW, or RW+1018 ISS treatments, 2 weeks rest, and a final RW challenge 24 hours before sacrifice. B, BALF cytokines and eosinophils (mean ± SEM, 5 mice/group). *P<0.05, **P<0.01, or ***P<0.0001, compared to RW. 1 representative experiment of 4 shown.